Targeting TLR4 with ApTOLL Improves Heart Function in Response to Coronary Ischemia Reperfusion in Pigs Undergoing Acute Myocardial Infarction

Toll-like receptor 4 (TLR4) contributes to the pathogenesis of coronary ischemia/reperfusion (IR). To test whether the new TLR4 antagonist, ApTOLL, may prevent coronary IR damage, we administered 0.078 mg/kg ApTOLL or Placebo in pigs subjected to IR, analyzing the levels of cardiac troponins, matrix...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomolecules
Egile Nagusiak: Ramirez-Carracedo, Rafael, Tesoro, Laura, Hernandez, Ignacio, Diez-Mata, Javier, Piñeiro, David, Hernandez-Jimenez, Macarena, Zamorano, Jose Luis, Zaragoza, Carlos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464507/
https://ncbi.nlm.nih.gov/pubmed/32784904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10081167
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak